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The selective extraction of specific proteins (non-glycosylated, glycosylated or different glycoforms) from complex sample matrices 
utilising selective solid phase extration (SPE) is of significant interest within the fields of proteomics and glycoproteomics. Polymer 
monoliths have proven to be an excellent solid support for SPE applications in bio-analysis due to their excellent mass transfer 
characteristics for large biomolecules. Although biorecognition molecules such as lectins can be covalently immobilised directly onto the 
monolith surface using a variety of chemistries, the relatively low surface area of these monoliths results in a correspondingly low sample 10 
capacity. Recently, we have described the covalent attachment of 20 nm gold nanoparticles (AuNPs) upon a polymer monolith with 
excellent surface coverage leading to a significant increase in surface area. In this work therefore we describe the in-situ preparation of 
an ethylene dimethacrylate porous polymer monolith within the confines of 20 µL polypropylene pipette tips, onto which methacrylate 
anchor sites were previously grafted to ensure intimate monolith/wall contact. Then AuNPs were immobilised onto the monolith pore 
surface utilising azlactone cemistry. Field emission scanning electron microscopy was used to verify the high surface coverage of 15 
AuNPs. Erythrina cristagalli lectin (ECL) was immobilised upon the attached AuNPs via a biofunctional linker. The ECL-modified tip 
was successfully applied for the enrichment of galactosylated protein (desialated transferrin) versus a non-galactosylated protein 
(ribonuclease B) due to the specificity of ECL. Reversed-phase capillary HPLC was used to validate the efficiency and selectivity of the 
developed micro-extraction phase which resulted in an increase in extraction recovery of ~95 % in the presence of AuNPs. The 
specificity of the ECL-modified tip was further studied by using more complex mixture of proteins which included non-glycosylated 20 
proteins and glycosylated proteins with different terminal sugar structure. Finally, the lectin affinity extraction device was tested with a 
real sample (E. coli cell lysate) spiked with target galactosylated glycoproteins. 
Introduction. 
Most analytical methods require some form of sample preparation 
and quite often a significant amount of time is invested in the 25 
development of appropriate sample preparation strategies. 
Liquid-liquid extraction, ultracentrifugation, and solid phase 
extraction (SPE) are the most common techniques for sample 
preparation.1 Among them, SPE is the simplest, most effective 
and most versatile technique. Generally, it is applied to the 30 
selective capture and preconcentration of the target analyte and/or 
the removal of potentially interfering components from the 
sample matrix.1-4 SPE has been applied as a sample preparation 
strategy both for small molecules (pharmaceutical, pesticides etc) 
as well as larger biomolecules (peptides, proteins etc). SPE 35 
devices usually comprise a selective adsorbant material encased 
within a housing such that the sample and subsequent elution 
buffers can be passed through the bed for collection and analysis. 
Traditionally, the selective adsorbant is held within a flow-
through cartridge device and the sample is manually loaded onto 40 
the top of the packed bed and eluted with the assistance of an 
applied vacuum. However when working with small volumes 
(<50 µL), SPE has increasingly been performed in different 
formats such as capillaries, the channels of a microfluidic device, 
or in commercial pipette tips. The advantages of SPE in pipette-45 
tip formats include ease of use, small sample and solvent volumes 
as well as the possibility to process many samples at the same 
time using either multi-channel hand-held pipettes or robotic 
liquid handling systems.5-7 
 Traditional SPE sorption materials are beads packed in a 50 
cartridge or column. In addition, packed SPE-in-MPT (solid 
phase extraction in a micropipette tip) has been applied for 
enrichment, purification, desalting and fractionation of different 
biological samples using either home-made or commercially 
available tips.8-14 For example, Kussmann et al. used a home-55 
made tip that was prepared by filling a bottom-end squeezed 
GelLoader tip (Eppendorf, Hamburg, Germany) with a 
suspension of Poros materials (PerSeptive Biosystems, 
Framingham, MA, USA) to form a purification column10 whereas 
Šalplachta et al. used the commercially available ZipTip C18 tips 60 
from Millipore (Billerica, MA, USA) for desalting tryptic digests 
of fractionated proteins.12 However, there are some difficulties 
and drawbacks associated with the preparation of this kind of 
tips.8,15-17, most notably the requirement for inclusion of retaining 
frits. As an alternative, many of these drawbacks can be 65 
overcome by the use of monolithic sorption beds. Since the early 
to mid-1990’s great attention has been paid to monolithic 
sorption beds due to the various features that they have which 
include (i) the ease of fabrication, in particular, for microscale 
utilisation as there is no need for frits, (ii) operation at high linear 70 
velocity due to high permeability and good mass-transfer, (iii) 
different surface functionality and selectivity can be achieved 
and, (iv) chemical stability at a wide pH range.18,19 Monolithic 
beds are generally classified into two categories: silica and 
organic polymer monoliths. Silica monoliths are manufactured by 75 
sol-gel technology with phase separation and have been used for 
fabricating SPE-in-MPT.16,20-23 Miyazaki et al. prepared a 
monolithic silica bed fixed in a 200 µL pipette tip in which the 
silica surface was modified with a C18 phase or coated with titania 
phase and applied that for sample concentration, desalting and 80 
purification as well as selective extraction of phosphorylated 
peptides.16 Hasegawa et al. [REFERENCE number here] and 
Kumazawa et al. [REFERENCE number here] demonstrated the 
effective use of the commercially available monolithic silica tips 
(MonoTip C18) for the extraction of antihistamines from human 85 
plasma20,21 as well as methamphetamine and amphetamine from 
human urine22 and human whole blood.23 On the other hand, 
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organic polymer monoliths are produced by one-step 
polymerisation of a mixture consisting of organic monomers, 
crosslinkers, porogenic solvents and initiators. The mixture is 
sonicated, purged under nitrogen, filled in a micropipette tip to a 
certain volume and irradiated with UV. Several studies have 5 
described the preparation and application of polymer monoliths in 
SPE-in-MPT for the analysis of the biological samples.15,24-29 For 
example, Rainer and co-workers fabricated a divinylbenzene-
based extraction tip for selective enrichment of phosphorylated 
peptides and successfully applied that to the study of in vitro 10 
phosphorylation.24 Abdel-Rehim et al. introduced a set-up of 
polypropylene methacrylate-based monolithic tips for use with 
96-well plates. It was applied for clean-up the beta-blocker 
pindolol and metoprolol in human plasma samples.25  
 Despite of all the advantages of the monoliths mentioned 15 
above, the low surface area of these materials relative to silica 
monolith somewhat restricts the applicability of these materials. 
Strategies to increase the surface area of polymer monoliths have 
mainly focussed on the incorporation of selected 
nanoparticleseither during [24, 29,30..also Krenkova, Anal Chem, 20 
2010, 82 pp 8335] or after polymerisation [31]. Depending on the 
nature of the nanoparticle the selectivity of the final modified 
monolith can also be tuned for a specific application. For 
example, Krenkova et al. [Anal Chem, 2010, 82 pp 8335] 
recently incorporated hydroxyapatite nanoparticles into the 25 
polymerisation mixture during production of a polymer monolith 
which was subsequently used for separation of proteins and 
enrichment of phosphopeptides (by virtue of the hydroxyapatite 
nanoparticles exposed at the monolith surface). 
 Recently, we produced a high-density Au-immobilised 30 
monolith in which the AuNPs were immobilised on the surface of 
the preformed monolith utilising azlactone chemistry surface 
modification.32 Using a different strategy Xu et al. prepared a 
GMA-co-EDMA monolithic capillary column modified with 
AuNPs for selective capturing of cysteine-containing peptides. 35 
The epoxy groups were first reacted with cysteamine to expose 
thiol moieties on the surface and then chloroauric acid was in situ 
reduced to form AuNPs attached to the thiol groups.33 This work 
was quickly followed by Cao et al. [Anal Chem 2010, 82 pp 
7416] who used the same gold modified monolith as an 40 
“exchangable” surface which could be readily functionalised with 
either reversed phase or ion-exchange functionalities for the 
separation of selected peptides and proteins.  
 Monolithic materials have shown excellent utility as support 
for affinity chromatography for separation of bimolecules due to 45 
the mass-transfer properties that they exhibited. Different 
bioligands have been immobilised on monolithic surface such as 
protein A for biospecific separation of immunoglobulins,34 
mannan for separation of mannose-binding proteins,35 
concanavalin A (Con A) and wheat germ agglutinin (WGA) for 50 
isolation and preconcentration of glycoconjugates,36 carbohydrate 
for affinity of lectins37 and trypsin immobilised on a monolithic 
pipette tip for rapid proteins digestion.38 
 In the work reported here, we describe the successful 
modification of a polymer monolith in pipette-tip format with 55 
gold nanoparticles and, via the use of a commercial bifunctional 
coupling agent DTSP, the covalent attachment of a selected lectin 
for affinity extraction of glycoproteins from samples of varying 
complexity. 
Experimental 60 
Reagents and materials 
Benzophenone, 2,2-dimethoxy-2-phenylacetophenone (DPA), 
ethylene glycol dimethacrylate (EDMA), lauryl methacrylate 
(LMA), 1-decanol, ethylenediamine, gold(III) chloride trihydrate, 
3,3′-dithiodipropionic acid di(N-hydroxysuccinimide ester) 65 
(DTSP), transferrin (human), ribonuclease B, insulin (bovine 
pancreas), insulin chain B (oxidized from bovine pancreas), 
enolase (S. cerevisiae), thyroglobulin from porcine thyroid gland, 
carbonic anhydrase (bovine), cytochrome c (equine), manganese 
(II) chloride tetrahydrate, calcium chloride hexahydrate, D-(+)-70 
galactose (Gal), 1,4-butanediol, 1-propanol, Trizma 
hydrochloride, sodium citrate, 4-(2-hydroxyethyl)piperazine-1-
ethanesulfonic acid (HEPES, ≥99.0%), dimethylsulphoxide 
(DMSO) and trifluoroacetic acid (TFA, 99%) were purchased 
from Sigma-Aldrich (Dublin, Ireland). Trizma base (≥99.0%), 75 
sodium chloride and bovine serum albumin were from Fluka 
(Buchs, Switzerland). 4,4-dimethyl-2-vinyl-2-oxazolin-5-one 
(vinyl azlactone) was purchased from TCI Europe (Zwijndrecht, 
Belgium). Unconjugated Erythrina cristagalli lectin (ECL) was 
provided by Vector Laboratories (Peterborough, UK). 80 
Clostridium perfringens neuraminidase was purchased from New 
England BioLabs (Hitchin, UK). PNGase was purchased from 
New England BioLabs. The 20-µL polypropylene (PP) tips used 
for in-situ fabrication of monolith were from Brand (Wertheim, 
Germany). Methanol, ethanol, acetone and acetonitrile were of 85 
HPLC grade and purchased from Fisher Scientific (Dublin, 
Ireland). All chemicals were used as received without further 
purification. Teflon-coated fused silica capillary (100 µm i.d.) 
was supplied by Composite Metal Services (Shipley, England).  
Instrumentation 90 
Photopolymerisation and photografting were carried out using a 
Spectrolinker XL-1000 UV Crosslinker at 254 nm (Spectronics 
Corp., Westbury, NY, USA). The balance used was a Sartorius 
Extend (Sartorius, Goettingen, Germany).  The sonication bath 
used was from Branson Ultrasonics Corporation (Danbury, CT, 95 
USA). A KD Scientific syringe pump (KDS-100-CE, KD 
Scientific Inc, Holliston, MA, USA) was used for all washing and 
functionalisation of monoliths in pipette-tip formats as well as 
trap/release of protein mixtures. Scanning electron microscopy 
(SEM) was performed on a 1 mm long cross-section of the 100 
unmodified monolith using a Hitachi S-3400N instrument 
(Hitachi, Maidenhead, UK) after sputtering the sample with gold 
using a SputterCoater S150B (BOC Edwards, Sussex, UK). To 
visualise the coverage of AuNPs on cross-sections of gold-
modified monoliths previously removed from their housings (as 105 
described later) and mounted on carbon grids, a Hitachi S-5500 
Field emission SEM (Hitachi, Maidenhead, UK) was used. 
Chromatography was performed using a Dionex Ultimate 3000 
Capillary LC system (Dionex, Sunnyvale, CA, USA) at a flow 
rate of 2 µL.min-1. The injection volume was 1 µL, with detection 110 
by UV at 214 nm using a 3 nL flow-cell. Mobile phase A was 
0.1% TFA in water and mobile phase B was 0.1% TFA in 90% 
acetonitrile. For the separation of ribonuclease B and desialated 
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transferrin a 10 minute gradient of 5 % B to 100 % B was applied 
at 25 oC. All other separations involved a 9 minute gradient (5 % 
B to 100 % B) at 40 oC. The monolithic column used was 
prepared by filling a 100 µm x 15 cm vinylised39 fused silica 
capillary with a deoxygenated mixture of 24 wt% LMA, 16 wt% 5 
EDMA, 14.5 wt% 1,4 butandiol, 45.5 wt% propanol and 1 wt% 
DPA (w.r.t monomers) followed by irradiation with 2 J.cm-2 UV 
energy at 254 nm. The resulting monolith was washed with 
MeOH for 2 hours at the flow rate of 2 µL.min-1 to remove the 
porogen and unreacted monomers.  10 
Modification of the polypropylene tip surface. 
Prior to in-situ fabrication of the monolith in the tip, the inner 
surface of the polypropylene tip was modified with grafted chains 
of EDMA. Firstly, the tip was washed with 10 µL EtOH (10 
times) and 10 µL acetone (10 times) and dried using nitrogen to 15 
remove any impurities on the surface of the polypropylene. The 
tip was filled with 10 µL of deoxygenated 5 % benzophenone in 
methanol and irradiated with 1 J.cm-2 UV energy at 254 nm 
followed by a thorough methanol rinse. The tip was then filled 
with deoxygenated 15 % EDMA in MeOH and irradiated using 20 
the same conditions Finally, the tip was washed thoroughly with 
MeOH and dried with nitrogen before use. 
Preparation of the polymer monolith within the modified 
pipette-tip housing. 
A polymerisation mixture consisting of EDMA (40 wt%), 1-25 
decanol (60 wt%) and DPA (1 wt%, w.r.t monomer) was 
prepared, sonicated for 30 minutes and deoxygenated with a 
nitrogen flow (10 minutes). In order to ensure a constant and 
repeatable bed volume for each monolith, a guide ring of 
polypropylene (2 mm i.d.) was slipped over the outside of the 30 
modified tip, which was subsequently filled by capillary action 
until the meniscus reached the bottom of the guide ring. The 
filled tip was placed upright in a coned centrifuge tube 
(polypropylene) and irradiated with 3 J.cm-2 UV energy at 254 
nm, resulting in a monolith which was finally washed with 35 
MeOH at flow rate of 100 µL.h-1 to remove the porogen and any 
unreacted monomers. In some instances, an attempt was made to 
prepare a main channel through the centre of the monolith to 
facilitate lower operating backpressures. This was achieved by 
inserting a section of either 150 µm o.d. or 360 µm o.d. fused 40 
silica capillary down the bore of the monomer-filled tip prior to 
polymerisation followed by the removal of this template 
afterwards as described by Hsu et al. [15] 
 
Immobilisation of AuNPs on the monolithic surface. 45 
Firstly, AuNPs (20 nm) were prepared using the citrate reduction 
method as described elsewhere by Frens.40 Based on the 
measured absorbance at 520 nm and an extinction coefficient of 1 
X 109 M-1.cm-1, the concentration of colloidal gold was 1.17 x 10-
9 M (or 7.05 x 1011 particles.mL-1).  50 
 The attachment of gold nanoparticles to the monolith surface 
first involved the amination of the monolith surface as described 
by Connolly et al.32 The monolith was first conditioned with 50 
µL MeOH followed by flushing the monolith with a 
deoxygenated solution of 5 % benzophenone in MeOH for 30 55 
minutes. The monolith was then irradiated with 3 J.cm-2 UV 
energy at 254 nm followed by washing with MeOH for 30 
minutes. The monolith was then flushed with a deoxygenated 
solution of 15 % vinyl azlactone in MeOH for 30 minutes and 
subjected to the same irradiation cycle. After a preliminary wash 60 
with MeOH, the monolith was washed with water for 30 minutes 
prior to flushing with 1 M ethylenediamine for a nominal time of 
4 hours. The monolith was again washed with water (until 
monolith rinsings were pH neutral) to remove free 
ethylenediamine. Finally, the aminated monolith was flushed 65 
with AuNPs (approx. 2 mL). Immobilisation of AuNPs was 
considered to be complete after the entire monolith bed had 
turned a deep red colour. The gold-modified monolith was 
washed with 1 mL water to remove unbound gold nanoparticles. 
The axial homogeneity of AuNPs coverage along the monolith 70 
bed was readily evaluated using an optical microscope. The 
coverage of AuNPs on the monolith was examined using FE-
SEM as previously described. 
Covalent attachment of ECL to immobilised AuNPs. 
The AuNP-modified tip was conditioned with 50 µL of DMSO 75 
and then flushed with 25 mM DTSP in DMSO for 4 hours. The 
monolith was then washed with DMSO for 30 minutes to remove 
any unreacted coupling agent followed by deionised water for 30 
minutes. Subsequently, the monolith was conditioned for 30 
minutes with 10 mM HEPES buffer pH 8.2 containing 1 mM Ca2+ 80 
and 1 mM Mn2+ followed by flushing a 1 mg.mL-1 solution of 
ECL prepared in the same buffer for 4 hours at room temperature. 
Finally, in order to block any unreacted succinimidyl groups, the 
resulting ECL-modified monolith was flushed with a primary 
amine (1 M Tris buffer pH 7.4) followed by a 100 µL deionised 85 
water wash. When not in use, the ECL-modified monolith was 
kept immersed in 10 mM Tris buffer pH 7.4 containing 150 mM 
NaCl, 1 mM Ca2+ and 1 mM Mn2+ at 4 oC. For the sake of clarity, 
this monolith shall be referred to hereafter as Monolith A. In 
order to investigate the effect of AuNP modification of the 90 
monolith, a comparison monolith (Monolith B) was also 
prepared which did not incorporate immobilised AuNPs. Instead, 
the monolith was grafted with vinyl azlactone as described, and 
then ECL was immobilised onto the resulting pendant azlactone 
moieties using the same immobilisation buffer followed by 95 
blocking with 1 M Tris buffer. 
 Additionally, in order to investigate the origin of unwanted 
non-specific interactions between test proteins and the gold-
modified substrate, a further four monoliths were prepared 
(referred to as “blank” monoliths in that they did not include 100 
immobilised ECL). Blank Monolith 1 did not include 
immobilised AuNPs but was grafted with polymer chains of vinyl 
azlactone and blocked with 1 M Tris buffer. Blank Monolith 2 
was modified with AuNPs which were not blocked with 1 M Tris 
buffer. Blank Monolith 3 was modified with AuNPs which were 105 
subsequently blocked with 1 M Tris buffer. Blank Monolith 4 
was modified with AuNPs, functionalised with DTSP and the 
resulting succinimidyl groups blocked with 1 M Tris buffer. 
Figure 1 illustrates a schematic diagram of the different 
monoliths prepared. 110 
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Figure 1: Schematic diagram of all affinity monoliths and blank 
monoliths prepared in this study. Key: (a): aminated azlactone polymer 
grafts, (b): bare AuNP, (c): AuNP modified with DTSP, (d): AuNP 
blocked with Tris, (e) AuNP modified with DTSP followed by Tris 5 
blocking, (f): ECL protein, (g): azlactone polymer grafts blocked with 
Tris. 
Desialation of transferrin and thyroglobulin.  
Desialated transferrin and thyroglobulin was prepared by treating 
them with Clostridium perfringens neuraminidase and following 10 
the supplier instructions. Briefly, 100 µg of the protein was 
prepared in 50 mM sodium citrate pH 6.0, mixed with 50 U 
neuraminidase and left to react at 37oC for overnight. 
Deglycosylation of transferrin. 
Transferrin was deglycosylated using Flavobacterium 15 
meningosepticum PNGase F following the supplier instructions. 
Briefly, 100 µg of the protein was prepared in 50 mM sodium 
phosphate pH 7.5 mixed with 500 U PNGase F and left to react at 
37oC for overnight. 
Bind and elute studies 20 
A number of selected proteins were used to study the binding 
affinity of all fabricated monoliths and also to evaluate the 
blocking strategies used to eliminate non-specific interactions (ie: 
binding which was not due to strictly lectin-glycoprotein 
interactions). All lectin affinity monoliths and blank monoliths 25 
were tested using the syringe pump at a flow rate of 50 µL.hour-1. 
The tip was first conditioned with 20 µL of loading buffer (10 
mM Tris pH 7.4 containing 150 mM NaCl, 1 mM Ca2+ and 1 mM 
Mn2+). A test mix of selected proteins (total volume: 20 µL) was 
prepared in loading buffer and loaded from the top-end, pumped 30 
through the tip and collected in a clean 1.5 mL centrifuge tube 
followed by a 20 µL buffer wash which was collected in the same 
tube and combined with the extracted mixture. Preliminary 
binding studies and all evaluations of “blank monoliths” (Blank 
Monoliths 1 to 4) involved the use of a simple mix of two 35 
glycoproteins: desialated transferrin and ribonuclease B (20 
µg.mL-1 each). Further more rigourous testing of the affinity 
monoliths involved the use of a more complex protein mixture 
containing up to nine proteins as described later. An E. coli cell 
lysate spiked with transferrin was also used to test the affinity 40 
monolith. In all cases, to elute any retained glycoprotein, 40 µL 
of 0.8 M galactose prepared in buffer solution was flushed 
through the tip and collected for analysis by LC. 
Results and discussion 
Fabrication of porous polymer monoliths in pipette tip 45 
format. 
The fabrication of porous polymer monoliths in pipette-tip 
formats has been reported before [include REFerences] however 
in the work described herein, we report for the first time the in-
situ covalent attachment of gold nanoparticles to the 50 
polypropylene-encased monolith resulting in two distinct 
benefits. Firstly, the surface area can be significantly increased 
resulting in increased loading capacity when a selective lectin is 
immobilised onto the gold surface. Secondly, the use of a gold 
surface and a commercially available bi-functional linker (DTSP) 55 
means that the extraction device is readily suited for the 
immobilisation of any bio-recognition molecule via the reaction 
between pendant succinimidyl groups and native lysine residues 
(from Protein A for trapping immunoglobulins to enzymes such 
as trypsin or PNGase for off-line enzymatic digestion). In our 60 
study however, we elected to immobilise a galactose-selective 
lectin (ECL) on the gold surface as a simple test-case, in order to 
examine the trap-and-release of various selected glycoproteins. 
Why was ECL chosen over other lectins? Include references to 
back up answer).The performance of the resulting ECL affinity 65 
monolith was also compared directly with that of an ECL affinity 
monolith which did not incorporate AuNP, but rather where the 
lectin was instead immobilised directly onto the lower surface 
area monolithic substrate itself via grafted chains of amine-
reactive poly(vinyl azlactone). 70 
 The initial task was of course to form a porous polymer 
monolith in-situ within the confines of a selected plastic pipette 
tip and in this regard the strategies employed were largely similar 
to those described previously.15,24-29 Pipette tips manufactured 
from polypropylene were selected since polypropylene is 75 
resistant to all solvents employed in this study and was found to 
be sufficiently UV transparent to facilitate all UV-initiated 
photografting and polymerisation events. Also, as described by 
Stachowiak et al. [Electrophoresis 2003, 24, 3689–3693] 
polypropylene is highly suited as a substrate for the photografting 80 
of selected monomers since it contains easily abstractable 
hydrogens (photografting is mediated by benzophenone and 
proceeds due to hydrogen abstraction from the surface of the 
substrate [Rånby, B., Yang, W. T., Tretinnikov, O., Nucl. 
Instrum. Methods Phys. Res. Sect. B 1999, 151, 301–305] and 85 
[Rohr, T., Ogeltree, D. F., Svec, F., Fréchet, J. M. J., Adv. Funct. 
Mat. 2003, 13, 264–270]. Therefore, polymer chains of EDMA 
were photografted to the walls of the pipette tip to ensure intimate 
covalent bonding between the EDMA monolith bed 
(subsequently polymerised in-situ) and the polypropylene wall, 90 
thereby preventing sample loss due to unwanted wall voids. This 
also conferred greater structural rigidity to the monolith, 
preventing it from detaching from its housing during operation. 
 The pipette tip housing was naturally cone-shaped, resulting in 
a limited degree of support for the monolith within, but the 95 
advantage of wall modification via photografting was readily 
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demonstrated by driving high pressure nitrogen through the 
monolith bed in the opposite direction i.e. from the tapered end. 
Resistance to this pressure was significantly higher for monoliths 
in wall-modified tips relative to monoliths in unmodified tips 
which easily became detached from their housings (which 5 
incidentally facilitated the evaluation of AuNP coverage via FE-
SEM methods). 
 
Figure 2. Scanning electron microscopy images of a porous polymer 
monolith formed within a polypropylene pipette tip which was modified 10 
by photografting (a,c) and unmodified (b,d) prior to monolith 
polymerization. 
 Figure 2 shows SEM images of a monolith formed within a 
pipette tip with and without wall modification. Clearly the wall 
modified tip (a,c) resulted in direct covalent attachment of the 15 
monolith whereas the unmodified tip (b,d) resulted in a monolith 
which is shaped like a truncated cone merely by virtue of the 
shape of its housing, but around which a large void is clearly 
visible.  
 Previous studies have suggested creating a main channel 20 
through the monolith15,29 to reduce backpressure and facilitate the 
use of a simple laboratory autopipette. However, two issues 
occurred during the fabrication and modification process of the 
monolithic tip when the channel was created. Firstly, the channel 
was close to the tip wall and it was difficult to reproducibly 25 
position it in the centre of the monolithic bed. It was considered 
that this issue could negatively affect the trap-elution of the 
analyte due to uneven fluid flow through the monolith pore 
network. Secondly, the subsequent modification (with AuNP) of 
monoliths incorporating a main channel did not occur evenly 30 
throughout the entire monolith. Rather, the coverage of AuNP 
was centred around the bore of the main channel such that the 
radial homogeneity of immobilised AuNP was poor. 
Consequently, the absence of a main flow-through channel 
resulted in high backpressures which prohibited the use of hand-35 
held auto-pipettes for sample loading and rinsing, necessitating 
the use of a syringe pump. Efforts were made to reduce the 
backpressure by varying the monomer concentration between 
20% and 40% prior to polymerisation, but all monoliths with < 
40% EDMA had very poor mechanical rigidity. However the 40 
main focus of our efforts in this work was to demonstrate the use 
of gold-modified monoliths in pipette tips for affinity applications 
and thus the means by which the monolith was flushed was 
considered incidental. Finally, the reproducibility of monolith bed 
size was acheived by the use of an o-ring placed on the outside of 45 
the tip such that each empty photografted tip could be accurately 
filled with a given volume of monomer mixture. Other studies 
have reported the placement of o-rings inside the tip for this 
purpose15 but this strategy was avoided due to the possible 
generation of a void volume between the top of the monolith bed 50 
and the o-ring. The monolith bed size was measured under an 
optical microscope using a vernier caliper and a % RSD of 8 % 
achieved for 8 separately prepared monoliths. 
Modification of the monolith with gold nanoparticles. 
The covalent attachment of gold nanoparticles onto the polymer 55 
monolith with a high density of coverage was achieved using a 
protocol originally described by Connolly et al.32 with minor 
modifications. This protocol was broadly divided into two steps; 
amination of the monolith surface by reacting grafted polymer 
chains of vinyl azlactone with ethylenediamine, and the 60 
subsequent flushing of the monolith with 20 nm citrate-stabilised 
gold nanoparticles. One particular matter of concern was the 
possibility that the UV radiation (during grafting of azlactone) 
might not penetrate through the entire bulk of the monolith (due 
to the screening effect of UV absorbing monomers, solvents and 65 
the monolith itself) leading to an unwanted radial gradient of 
graft density. Rohr and Ogletree [Rohr, T., Ogeltree, D. F., Svec, 
F., Fréchet, J. M. J., Adv. Funct. Mat. 2003, 13, 264–270]. have 
previously demonstrated that homogeneous grafting can be 
achieved through a 200 µm thick layer of monomer and also 70 
investigated the effect of rotating the substrate during grafting 
events [Rohr et al. (Macromolecules, Vol. 36, No. 5, 2003] In 
their study, Rohr et al. (Macromolecules as above) used electron 
probe microscopy to evaluate the homogeneity of graft density 
(for sulphonated polymer grafts). However, since we were 75 
immobilising 20 nm AuNP via aminated azlactone graft sites, we 
elected to evaluate AuNP coverage by FE-SEM which we took to 
be indicative of graft homogeneity since each nanoparticle is very 
strongly attached by multi-point interactions to the grafted 
surface via primary amine lone-pair electrons (Svec and 80 
Connolly).  
 Figure 3 illustrates the excellent coverage of AuNP. Figure 3a 
shows that the edge of the monolith (adjacent to the wall) had 
rather a sparse coverage of AuNP’s which extended some 7 µm 
into the centre of the monolith. 85 
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Figure 3. Field emission scanning electron microscopy images of a porous polymer monolith agglomerated with covalently attached 20 nm AuNP. (a): 
8,000X magnification. The dashed lines represent a 7 µm region of monolith with lower AuNP coverage. (b): 60,000X magnification.  
 
We believe that the poor coverage in this very narrow zone 5 
(representing only 3.5 % of the entire 400 µm monolith radius) 
was due to poor convective fluid flow at the extremities of the 
monolith compared with flow through the remaining monolith 
bulk. In relation to the work of Rohr et al (Adv Funct Mater paper 
and Macromolecules paper) regarding the radial homogeneity of 10 
grafting, for the work presented here, no gradient of grafting 
density was observed, either axially or radially despite the fact 
that our monolith was of considerably larger dimensions (400 µm 
at the tip). The high surface coverage of AuNP likely led to a 
significant increase in surface area however the very small 15 
monolith bed volume and the photografting methods used 
precluded any possible use of BET analysis to accurately 
quantitate the surface area increase. The number of individual 
gold-agglomerated monoliths required to provide a high enough 
mass of material for BET analysis was prohibitively high. In 20 
addition, fabricating a larger single monolith in a bigger mould 
for BET analysis was not considered since complete coverage of 
AuNP’s throughout the entire bulk of the larger monolith would 
likely not be achieved due to excessively large monolith 
diameters inhibiting homogeneous grafting as previously 25 
discussed.  
 
Modification of the AuNP-modified monolith with ECL  
A number of different strategies were considered for the 
immobilisation of ECL on the gold-modified surface. The 30 
simplest method (which was not adopted here) would be to flush 
the gold surface with a solution of ECL as suggested by Storri et 
al [43] such that the lectin is physically adsorbed on the bare gold 
surface. However, this interaction is known to be weak and the 
adsorbed lectin could easily leach from the Au surface during the 35 
subsequent use of the extraction device.[43]. An alternative 
method resulting in covalent attachment to the gold surface 
involved the use of a bi-functional linker, DTSP as described by 
Katz [Katz paper on DTSP Katz, E.Y., 1990. J. Electroanal. 
Chem. 291, pp. 257–260.] Figure 4 shows the DTSP coupling 40 
reaction between the gold surface and ECL. The AuNP-modified 
monolith was first flushed with DTSP to form a self-assembled 
monolayer of N-succinimidyl-3-thiopropionate (NSTP).44[also, Katz] 
via strong gold-sulphur bonds. NSTP has an exposed active NHS 
group that is reactive towards primary amines; therefore covalent 45 
immobilisation of ECL was achieved by virtue of lysine residues 
on the exterior of the protein molecule[45].  
 
Figure 4. Reaction scheme for immobilisation of ECL via  DTSP 
coupling reagent. (For simplicity, the gold nanoparticles are illustrated as 50 
isolated particles rather than showing their multi-point attachment to 
aminated azlactone grafts on the monolith surface).  
The immobilisation buffer was selected to have a pH close to the 
optimum pH for lectin/glycan binding as dictated by the vendor 
and also incorporated 1 mM each of Ca2+ and Mn2+ which are 55 
known to be required metals for optimum protein 
folding/substrate binding/or binding site integrity....[reference?]. 
Therefore, by maintaining optimum buffer conditions for ECL 
during immobilisation and subsequent testing of the affinity 
monoliths, the risk of deactivation of ECL was minimised. 60 
 
Binding studies for ECL monolith: Ribonuclease B and 
transferrin. 
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ECL is known to be selective for glycoproteins with terminal 
galactose residues and for this reason two test glycoproteins were 
initially chosen for selectivity studies. Ribonuclease B was 
selected as the negative control since its glycan structures are 
terminated by mannose residues and thus this glycoprotein was 5 
not expected to be retained by the ECL affinity monolith. 
Conversely, transferrin was selected as the positive control 
protein. The glycan of transferrin is terminated by neuraminic 
acid residues. This necessitated their removal via neuraminadase 
to reveal underlying galactose residues. Trap and release studies 10 
involved loading a mixture of (conc?) both proteins onto the 
affinity monoliths followed by a rinse step. All fractions and 
combined monolith rinsings were immediately collected and 
subjected to capillary LC analysis to determine if selective 
binding had occured. 15 
 
Figure 5. Trap and release studies for ribonuclease B and transferrin on 
ECL affinity monoliths. (a) Ribonuclease B and transferrin standard, (b) 
standard mixture after passage through Monolith B, (c) standard mixture 
after passage through Monolith A, (d) Release of bound transferrin from 20 
Monolith A with a galactose rinse. Chromatographic conditions: Column: 
100 µm x 15 cm LMA-co-EDMA monolith, Gradient: 10 minute gradient 
from 5 %  B to 100 % B at 2 µL/min, Column temperature: 25 oC, 
Injection volume: 1 µL, Detection: UV at 214 nm. Peaks: (1) 
Ribonuclease B, (2) Transferrin (desialated). 25 
One of the advantages of using a AuNP-agglomerated monolith 
as a substrate for lectin affinity extractions is the obvious increase 
in available surface area when the test lectin (ECL) was 
immobilised onto the functionalised gold surface (Monolith A). 
Therefore for the sake of comparison, the binding capacity of 30 
Monolith A was compared directly with that of Monolith B which 
did not incorporate AuNP but instead had ECL covalently 
attached via amine-reactive azlactone polymer grafts, resulting in 
an anticipated lower binding capacity. As illustrated in Figure 5 
(using relative peak areas in standard Chromatogram (a) as a 35 
reference), transferrin was partially extracted by both Monolith A 
and Monolith B, relative to ribonuclease B whose peak area 
remained completely unaffected. This is clearly indicative of the 
selective retention of transferrin over ribonuclease B due to 
lectin-galactose interactions. However ~ 95 % more transferrin 40 
was retained on Monolith A relative to Monolith B, clearly 
showing the advantage of AuNP-modified monoliths as high 
surface-area substrates for lectin affinity devices (or indeed any 
affinity or solid-phase enzymatic digestion applications). A 
subsequent monolith rinse of Monolith A with 40 µL of 0.8 M 45 
galactose in loading buffer revealed that the bound transferrin 
could be readily recovered, appearing as a single peak in 
chromatogram (d). 
 
Investigation and mitigation of non-specific protein binding. 50 
The use of a AuNP-modified polymer monolith as a substrate for 
affinity extraction presents the obvious possibility that non-
specific binding of protein would occur, either due to 
hydrophobic interactions with the polymer monolith, gold-
sulphur/gold-amine interactions with the immobilised gold 55 
nanoparticles, or irreversible covalent attachment of proteins with 
exposed unreacted succinimidyl groups. 
 After immobilisation of ECL on the functionalised AuNP, 
tris(hydroxymethyl)aminomethane was used to block both the 
remaining succinimidyl groups and any bare gold adsorption 60 
sites. For the sake of completion therefore, four blank monoliths 
were prepared as described in Figure 1 and the ribonuclease 
B/transferrin standard was used to evaluate the extent of 
unwanted protein binding to the AuNP-monolithic substrate. The 
base monolith comprised EDMA as monomer and so 65 
hydrophobic interactions might be expected. However, further 
modification of this surface by azlactone grafting followed by 
extensive amination (to facilitate AuNP attachment) had the 
added advantage of rendering the monolith extremely 
hydrophilic. Since tris was used as a blocking agent throughout 70 
this work, Blank Monolith 1 (Figure 1) was prepared to 
demonstrate that this small hydrophilic amine was effective in 
eliminating any hydrophobic interactions as evidenced by the 
complete lack of retention of either test protein on the monolith 
surface after exposure to the test mix. Conversely, Blank 75 
Monolith 2 resulted in almost 100 % retention of both proteins 
due to the presence of bare unfunctionalised AuNP, presumably 
due to adsorption of protein on the gold surface as described by 
Storri et al. [43]. However, when the bare AuNP was blocked 
with tris to produce Blank Monolith 3, no detectable retention of 80 
either test protein was observed. Finally, the DTSP-functionalised 
AuNP monolith was blocked with tris and again no retention was 
observed (Blank Monolith 4), suggesting that tris, as a small 
hydrophilic amine was highly suited to providing efficient 
blocking of unreacted succinimidyl groups. 85 
 It should be noted that the loading buffer selected in this study 
was 10 mM Tris pH 7.4 containing 150 mM NaCl, 1 mM Ca2+ 
and 1 mM Mn2+. The buffer pH was selected to closely match the 
optimum binding pH of ECL. In addition, 150 mM NaCl was 
included in an effort to minimise any non-specific protein-protein 90 
interactions and thus limit all possible interactions to 
lectin/galactose. The composition of this loading buffer was not 
subject to exhaustive optimisation due to the observed absense of 
unwanted protein interactions in the blank monolith study. 
 95 
Extraction of two glycoproteins from complex mixtures. 
 Based upon the performance of the affinity monolith when 
tested with a relatively simple mixture of two glycoproteins, more 
complex test samples were prepared. The first sample included a 
mixture of nine selected proteins which included six non-100 
glycosylated proteins, (insulin chain B, insulin, cytrochrome C, 
bovine serum albumin, enolase and carbonic anhydrase) as well 
as glycoproteins which had either terminal mannose 
(ribonuclease B), or terminal galactose (desialated transferrin and 
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desialated thyroglobulin). In order to mimic a real sample, the 
non-glycosylated proteins were specifically selected to span a 
wide range of molecular masses from insulin chain B (3.5 kDa) to 
enolase (82 kDa to 100 kDa, depending on the isoform). A 
separate chromatographic method was developed for this mixture 5 
of nine test proteins. Using the same reversed phase monolith, a 
nine minute gradient (as described in the Experimental) was 
considered optimum. Column temperature (from 25 oC to 75 oC) 
however had a significant effect upon selectivity, particularly for 
three adjacent peak pairs. The optimised chromatogram of the 10 
standard mix is shown in Figure 6. Resolution between Peak 2 
and 3 increased from 0.9 at 25 oC to 2.5 at 75 oC, resolution of 
Peak 3 and 4 decreased from 3.6 at 25 oC to 1.2 at 75 oC and 
resolution of Peak 7 and 8 decreased from 2.0 at 25 oC to 
complete co-elution at 75 oC. As a compromise, a column 15 
temperature of 40 oC was selected which resulted in resolution 
between Peaks 2/3, 3/4 and 7/8 of 1.4, 2.5 and 1.7 respectively.  
The optimised gradient conditions resulted in a peak capacity of 
102.  
 20 
Figure 6. Test mix of nine proteins before (a) and after (b) extraction with 
Monolith A. Chromatogram (c) is after a galactose wash step. 
Chromatographic conditions as for Figure 5 except: Gradient: 9 minute 
gradient from 5 % B to 100 % B. Column temperature: 40 oC. Peaks: (1) 
20 µg/mL ribonuclease B, (2) 20 µg/mL insulin chain B, (3) 20 µg/mL 25 
insulin, (4) 20 µg/mL cytochrome C, (5) 25 µg/mL transferrin, (6) 25 
µg/mL BSA, (7) 20 µg/mL carbonic anhydrase, (8) 40 µg/mL enolase, (9) 
80 µg/mL thyroglobulin. 
When the test mix was passed through the affinity monolith 
(Monolith A), a comparison of chromatogram (a) and (b) in 30 
Figure 6 reveals that all of the non-glycosylated proteins (Peaks 
2-4 and 6-8) were unretained as expected. In addition, Peak 1 
(ribonuclease B) did not diminish in area since this glycoprotein 
has terminal mannose residues rather than terminal galactose. 
Conversely, significant levels of both desialated transferrin and 35 
thyroglobulin were extracted (decreased peak areas in 
Chromatogram b) and subsequently recovered with a galactose 
wash step. The lack of interfering peaks in the galactose wash is 
indicative of the specificity of binding. Interestingly, the affinity 
monolith was demonstrated to simultaneously extract both 40 
transferrin and thyroglobulin even in the presence of other 
proteins and glycoproteins, This was despite the considerable 
difference in size of both target glycoproteins (80 kDa and 660 
kDa respectively) and also the difference in glycan structure and 
coverage......????? 45 
 In a further effort to verify that transferrin had indeed been 
retained due to lectin-glycan interactions rather than non-specific 
protein-protein interations, two further experiments were 
performed. Firstly, transferrin was not treated with neuraminidase 
enzyme such that the transferrin glycan presented terminal sialic 50 
acid residues rather than terminal galactose. Incorporation of this 
untreated transferrin into a test mix (of all proteins except 
thyroglobulin) resulted in no extraction of transferrin when 
passed through the affinity monolith. Similarly, transferrin was 
treated with PGNase enzyme for removal of the entire glycan 55 
resulting in deglycosylated transferrin. Again, the deglycosylated 
transferrin was not extracted (data not shown).  
 It should be noted that throughout all of the extraction studies 
described in this report, the flow rate through the extraction 
device during loading and elution steps was not subjected to 60 
rigourous optimisation. Rather, the operational flow rate was 
chosen based on a compromise between one of the lowest 
possible flow settings on the syringe pump, and a flow rate at 
which reasonable volumes (> 20 µL) of eluted fractions could be 
collected in a reasonable timeframe. No doubt the recovery could 65 
have been significantly improved by optimisation of the flow rate 
and thus contact time between analyte protein and the 
immobilised lectin, however in this work our focus was largely 
on the qualitative assessment of the affinity monolith.  
Affinity monolith stability studies. 70 
During the course of this work a large number of affinity 
monoliths were prepared and some preliminary studies conducted 
on their short-to-medium term stability upon storage. As 
discussed, all monoliths were stored in 10 mM Tris pH 7.4 
containing 150 mM NaCl, 1 mM Ca2+ and 1 mM Mn2+ at 4 oC 75 
when not in use. Although a rigourous study of the stability of 
prepared affinity monoliths was not conducted, it was observed 
that affinity monoliths could retain their extraction capabilities 
after numerous consecutive periods of storage at 4 oC and re-use 
at room temperature. For example immediately after preparation, 80 
a particular monolith was stored for 12 hours at 4 oC, used for one 
extraction cycle (bind/elute), stored for a further 5 days at 4 oC, 
re-used for 6 consecutive extraction cycles, stored for 36 hours at 
4 oC and finally used for three extraction cycles. In all cases, the 
performance of the extraction device was excellent. More detailed 85 
stability testing shall be the subject of future studies although 
current data suggests that the extraction performance dropped off 
significantly after prolonged storage (> 1 month). 
 
Extraction of glycoprotein from spiked real samples: E. coli. 90 
Results presented thus far involved the use of protein standards 
prepared in the laboratory on the basis of their molecular weight, 
presence/absence of glycan structures and the nature of the 
terminal sugar unit on the glycan. As a final examination of the 
performance of the affinity monolith with real samples, an E. coli 95 
cell lysate (filtered and passed through a 10 kDa spin cartridge) 
was spiked with 20 µg/mL desialated transferrin. Figure 7 shows 
that the transferrin peak decreased significantly as a result of 
extraction despite the presence of unknown matrix protein. 
Indeed the peak profile of the E. coli proteins was remarkably 100 
 [Type text] [Type text] [Type text] 
unchanged before and after extraction which indicates that 
unwanted non-specific protein binding or protein-protein 
interactions were largely eliminated. Chromatogram (c) clearly 
shows that transferrin could readily be recovered from the 
extraction device and there was a marked absence of interfering 5 
proteins in this galactose elution step. Future work shall involve a 
more detailed examination of extraction recovery, but these 
preliminary results are extremely promising in terms of the 
development of a novel AuNP-modified monolithic substrate for 
affinity applications. 10 
 
Figure 7. Spiked E.coli cell lysate before (a) and after (b) extraction with 
Monolith A. Chromatogram (c) is after a galactose wash step. 
Chromatographic conditions as for Figure 6. Peaks: (1) 20 µg/mL 
transferrin. 15 
Conclusions 
A novel monolithic extraction device has been described which 
incorporates covalently attached gold nanoparticles resulting in a 
significant increase in surface area. By using the well studied 
bifunctional coupling agent DTSP, a selected lectin was 20 
successfully immobilised on the gold surface while retaining its 
activity. The obvious advantage of this new AuNP-modified 
substrate is that using DTSP chemistry, any bio-recognition 
molecule (lectins, enzymes, Protein A etc) can be immobilised 
depending upon the required application while taking full 25 
advantage of the excellent mass-tranfer characteristics afforded 
by the underlying porous polymer monolith. Although our 
evaluation of binding capacity was semi-quantitative at best, in 
our hands we nevertheless observed a clear increase in binding 
capacity by virtue of the increased surface area due to 30 
immobilised gold. Further studies in this area shall involve a 
more comprehensive evaluation of protein recovery, both in 
pipette tip format for offline extraction as well as in capillary 
formats for online sample cleanup. 
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